BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 32774915)

  • 1. miRNA-22 as a Candidate Diagnostic Biomarker for Coronary Slow Flow.
    Chen T; Wang ZY; Li CC
    Cardiol Res Pract; 2020; 2020():7490942. PubMed ID: 32774915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating miRNA-155 as a Potential Biomarker for Coronary Slow Flow.
    Su Q; Yang H; Li L
    Dis Markers; 2018; 2018():6345284. PubMed ID: 30046360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased plasma lipoprotein-associated phospholipase A2 levels are associated with coronary slow flow.
    Ding YD; Pei YQ; Wang R; Yang JX; Zhao YX; Liu XL; Shen H; Ma Q; Zhang S; Ge HL
    BMC Cardiovasc Disord; 2020 May; 20(1):248. PubMed ID: 32460702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between serum visfatin levels and coronary slow-flow phenomenon.
    Cakmak HA; Aslan S; Yalcin AA; Akturk IF; Yalcin B; Uzun F; Ozturk D; Erturk M; Gul M
    Herz; 2015 Sep; 40(6):921-8. PubMed ID: 25939438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eosinophil cationic protein: A new diagnostic biomarker in coronary slow flow phenomenon.
    Soylu K; Akcay M; Aksan G; Gedikli O; Gokay N
    Bratisl Lek Listy; 2021; 122(3):212-216. PubMed ID: 33618531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Relationship between plasma miR-126 and coronary slow flow phenomenon].
    Wang L; Wang HN; Zu XL
    Zhonghua Yi Xue Za Zhi; 2019 May; 99(17):1323-1327. PubMed ID: 31091580
    [No Abstract]   [Full Text] [Related]  

  • 7. Circulating microRNA-378 levels serve as a novel biomarker for assessing the severity of coronary stenosis in patients with coronary artery disease.
    Li H; Gao F; Wang X; Wu J; Lu K; Liu M; Li R; Ding L; Wang R
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 31064817
    [No Abstract]   [Full Text] [Related]  

  • 8. MicroRNAs in Human Cerebrospinal Fluid as Biomarkers for Alzheimer's Disease.
    Lusardi TA; Phillips JI; Wiedrick JT; Harrington CA; Lind B; Lapidus JA; Quinn JF; Saugstad JA
    J Alzheimers Dis; 2017; 55(3):1223-1233. PubMed ID: 27814298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Focusing on a complete blood cell parameter: mean platelet volume levels may be a predictor of coronary slow flow.
    Yılmaz M; Dağlı MN; Uku Ö; Bilen MN; Korkmaz H; Erdem K; Kurtoğlu E
    Vasc Health Risk Manag; 2017; 13():255-261. PubMed ID: 28740398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-941 as a promising biomarker for acute coronary syndrome.
    Bai R; Yang Q; Xi R; Li L; Shi D; Chen K
    BMC Cardiovasc Disord; 2017 Aug; 17(1):227. PubMed ID: 28830367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered serum microRNAs as novel diagnostic biomarkers for atypical coronary artery disease.
    Wang J; Pei Y; Zhong Y; Jiang S; Shao J; Gong J
    PLoS One; 2014; 9(9):e107012. PubMed ID: 25198728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum miRNA-499 and miRNA-210: A potential role in early diagnosis of acute coronary syndrome.
    Shalaby SM; El-Shal AS; Shoukry A; Khedr MH; Abdelraheim N
    IUBMB Life; 2016 Aug; 68(8):673-82. PubMed ID: 27346801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma atherogenic indices are independent predictors of slow coronary flow.
    Afsin A; Kaya H; Suner A; Uzel KE; Bursa N; Hosoglu Y; Yavuz F; Asoglu R
    BMC Cardiovasc Disord; 2021 Dec; 21(1):608. PubMed ID: 34930134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer.
    Zhu XL; Ren LF; Wang HP; Bai ZT; Zhang L; Meng WB; Zhu KX; Ding FH; Miao L; Yan J; Wang YP; Liu YQ; Zhou WC; Li X
    World J Gastroenterol; 2019 Apr; 25(13):1580-1591. PubMed ID: 30983818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma Choline as a Diagnostic Biomarker in Slow Coronary Flow.
    Zhu YT; Zhu LP; Wang ZY; Qiu XT; Wu WZ; Liu WW; Feng YY; Xiao WK; Luo X; Li ZY; Li CC
    Cardiol Res Pract; 2020; 2020():7361434. PubMed ID: 32411450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum expression of selected miRNAs in patients with laryngeal squamous cell carcinoma (LSCC).
    Lucas Grzelczyk W; Szemraj J; Kwiatkowska S; Józefowicz-Korczyńska M
    Diagn Pathol; 2019 May; 14(1):49. PubMed ID: 31138255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and diagnostic value of circulating miRNA-190 and miRNA-197 in patients with pulmonary thromboembolism.
    Zhou X; Wu Q; Hao T; Xu R; Hu X; Dong L
    J Clin Lab Anal; 2021 Jan; 35(1):e23574. PubMed ID: 32920929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of microRNAs in the cerebrospinal fluid as biomarker for the diagnosis of glioma.
    Baraniskin A; Kuhnhenn J; Schlegel U; Maghnouj A; Zöllner H; Schmiegel W; Hahn S; Schroers R
    Neuro Oncol; 2012 Jan; 14(1):29-33. PubMed ID: 21937590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic efficacy of fractional flow reserve with coronary angiography in dual-source computed tomography scanner.
    Xia G; Fan D; Yao X; Guan G; Wang J
    Acta Cardiol; 2018 Feb; 73(1):76-83. PubMed ID: 28830299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An investigation of the relationship between arterial aortic stiffness and coronary slow flow that was detected during coronary angiography.
    Genc Tapar G; Elcik D; Dogan A; Altunel E; Inanc MT; Alcali B; Boylug S; Oguzhan A; Topsakal R; Ergin A; Kalay N
    Echocardiography; 2020 Apr; 37(4):528-535. PubMed ID: 32240540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.